6505--Levetiracetam Tablets

The solicitation requires offerors to submit a detailed subcontracting plan that complies with FAR 52.219‑9 and VAAR 852.219‑70, including justification for any goals set below the VA‑suggested or prior‑year achieved levels, a specific list of potential sources (websites, associations, events, etc.), and a clear statement on whether indirect costs are included in the dollar and percentage goals. Separate dollar and percentage goals must be provided for each contract period (base and each option), and the plan must be approved before award for contracts exceeding $750,000. Offerors must also demonstrate good‑faith efforts to provide equitable opportunities to small, veteran‑owned, HUBZone, disadvantaged, and women‑owned businesses, with specific internal and external actions identified. Technical requirements focus on the supply of FDA‑approved pharmaceuticals listed in the Schedule of Supplies (various strengths and package sizes of Levetiracetam). Each offered product must have a unique National Drug Code, be produced at FDA cGMP‑acceptable facilities, and be listed on the offeror’s FSS contract or interim agreement with a permanent FCP by the offer deadline. Prices must include a 0.50 cost‑recovery fee, be firm for 120 calendar days, and be the lowest price technically acceptable offer. Offerors must complete the representations and provisions cited (e.g., FAR 52.209‑7, 52.219‑1, 52.204‑24, 52.225‑6) and submit quarterly sales reports and the collected cost‑recovery fees as required. Failure to meet any of these mandatory elements will result in rejection of the offer.

Notice ID

424dd3bd99834ef08ccbf9cc7899aa26

Solicitation Number

36E79726R0001

NAICS Code

325412

Classification Code

6505